Spectrascience Financial Statements From 2010 to 2025

Spectrascience New financial statements provide useful quarterly and yearly information to potential Spectrascience New investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Spectrascience New financial statements helps investors assess Spectrascience New's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Spectrascience New's valuation are summarized below:
Gross Profit
-196.4 K
Market Capitalization
4.9 K
Enterprise Value Revenue
K
Earnings Share
(0.01)
There are over one hundred nineteen available fundamental trend indicators for Spectrascience New, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Spectrascience New's current performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of March 17, 2025, Market Cap is expected to decline to about 1.3 M. In addition to that, Enterprise Value is expected to decline to about 9.5 M

Spectrascience New Total Revenue

4,403.25

Check Spectrascience New financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spectrascience New's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.4 M or Research Development of 937.2 K, as well as many indicators such as Price To Sales Ratio of 196, Days Sales Outstanding of 116 or Invested Capital of 0.0. Spectrascience financial statements analysis is a perfect complement when working with Spectrascience New Valuation or Volatility modules.
  
Check out the analysis of Spectrascience New Correlation against competitors.
For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.

Spectrascience New Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.5 M1.6 M1.9 M
Slightly volatile
Other Current Liabilities990.1 K942.9 K892.9 K
Very volatile
Total Current Liabilities13 M12.4 M8.6 M
Slightly volatile
Accounts Payable1.6 M1.5 M1.1 M
Slightly volatile
CashK3.2 K293.6 K
Slightly volatile
Other Assets88.4 K172.5 K139.5 K
Pretty Stable
Inventory77.5 K81.5 K147.2 K
Slightly volatile
Total Liabilities14.4 M13.7 M9.3 M
Slightly volatile
Common Stock10.7 M10.2 M6.5 M
Slightly volatile
Property Plant Equipment27028438.8 K
Slightly volatile
Other Liabilities1.2 M1.3 M1.2 M
Slightly volatile
Intangible Assets1.9 M1.2 M1.2 M
Very volatile
Preferred Stock Total Equity44.5 K27.9 K31.6 K
Slightly volatile
Short Term Investments1.6 M1.8 MM
Slightly volatile
Net Receivables81285516.5 K
Slightly volatile
Short and Long Term Debt5.1 M7.3 M5.2 M
Slightly volatile
Total Current Assets510.5 K325.7 K520.3 K
Slightly volatile
Short Term Debt5.1 M7.3 M5.2 M
Slightly volatile
Non Current Assets Total819.6 K922.1 KM
Slightly volatile
Non Currrent Assets Other819.6 K922.1 KM
Slightly volatile
Long Term Debt880 K990 K1.1 M
Slightly volatile
Non Current Liabilities Total904.7 KM1.1 M
Slightly volatile

Spectrascience New Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.4 M1.5 M1.8 M
Slightly volatile
Research Development937.2 K573 K833.7 K
Slightly volatile
Total Operating Expenses2.1 M2.2 M2.6 M
Slightly volatile

Spectrascience New Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities2.1 M1.6 M1.8 M
Slightly volatile
Other Cashflows From Investing Activities5.6 K6.3 K6.9 K
Slightly volatile
Sale Purchase Of Stock1.7 K1.8 K4.9 K
Slightly volatile
Net Borrowings1.6 M1.3 M1.7 M
Slightly volatile
Depreciation150.1 K145.1 K180.8 K
Slightly volatile
Change To Operating Activities716.6 K1.1 M775.6 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio196265190
Slightly volatile
Average Payables1.1 MM992.3 K
Slightly volatile
Stock Based Compensation To Revenue1.091.142.9717
Slightly volatile
Capex To Depreciation0.03730.03920.1795
Slightly volatile
EV To Sales1.6 K1.5 K1.2 K
Slightly volatile
Inventory Turnover2.081.981.5225
Slightly volatile
Days Of Inventory On Hand1421495.5 K
Pretty Stable
Payables Turnover0.250.170.1695
Pretty Stable
Sales General And Administrative To Revenue228218177
Slightly volatile
Average Inventory110.6 K116.4 K167.6 K
Slightly volatile
Research And Ddevelopement To Revenue11711192.9813
Slightly volatile
Capex To Revenue0.420.451.0961
Slightly volatile
Cash Per Share0.00.00.0026
Slightly volatile
Days Payables Outstanding2.1 K2.2 K40.2 K
Pretty Stable
Income Quality0.370.390.427
Slightly volatile
Intangibles To Total Assets0.390.670.6522
Pretty Stable
Current Ratio0.03660.03850.6197
Slightly volatile
Capex Per Share0.00.02.0E-4
Slightly volatile
Revenue Per Share0.00.04.0E-4
Slightly volatile
Interest Debt Per Share0.01090.01210.0131
Very volatile
Debt To Assets5.14.863.7303
Slightly volatile
Operating Cycle1992105.6 K
Pretty Stable
Days Of Payables Outstanding2.1 K2.2 K40.2 K
Pretty Stable
Ebt Per Ebit0.941.641.5832
Slightly volatile
Quick Ratio0.02740.02890.9574
Slightly volatile
Net Income Per E B T0.750.90.9677
Pretty Stable
Cash Ratio4.0E-44.0E-40.8805
Slightly volatile
Days Of Inventory Outstanding1421495.5 K
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.131.151.0286
Pretty Stable
Fixed Asset Turnover19.7418.815.7502
Slightly volatile
Debt Ratio5.14.863.7303
Slightly volatile
Price Sales Ratio196265190
Slightly volatile
Asset Turnover0.00320.00330.0232
Slightly volatile

Spectrascience New Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.3 M1.4 M3.7 M
Slightly volatile
Enterprise Value9.5 M10 M9.2 M
Pretty Stable

About Spectrascience New Financial Statements

Spectrascience New stakeholders use historical fundamental indicators, such as Spectrascience New's revenue or net income, to determine how well the company is positioned to perform in the future. Although Spectrascience New investors may analyze each financial statement separately, they are all interrelated. For example, changes in Spectrascience New's assets and liabilities are reflected in the revenues and expenses on Spectrascience New's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Spectrascience New. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue4.6 K4.4 K
Cost Of Revenue179.5 K170.5 K
Stock Based Compensation To Revenue 1.14  1.09 
Sales General And Administrative To Revenue 217.56  228.44 
Research And Ddevelopement To Revenue 111.25  116.82 
Capex To Revenue 0.45  0.42 
Ebit Per Revenue(545.79)(518.50)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Spectrascience New is a strong investment it is important to analyze Spectrascience New's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Spectrascience New's future performance. For an informed investment choice regarding Spectrascience Stock, refer to the following important reports:
Check out the analysis of Spectrascience New Correlation against competitors.
For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(0.92)
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.